The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: A prospective, multicenter, double-blinded, randomized, placebo-controlled trial

Michael G.L. Sarr, Eugene A. Woltering

Research output: Contribution to journalArticlepeer-review

148 Scopus citations

Fingerprint Dive into the research topics of 'The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: A prospective, multicenter, double-blinded, randomized, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences